Privacy Policy
Signals Blog

Contributors

Categories

The Canadian regulatory system for cell and gene therapies

Aileen J. Zhou brings over a decade of experience in biotech and medical device regulatory affairs. She is an active member and contributing author of the Regulatory Affairs Professional Society (RAPS) and Alliance for Regenerative Medicine’s Regulatory and CMC...

Crowning regenerative medicine’s official mascot: the axolotl

Cal Strode is a Communications Specialist at CCRM. Before joining CCRM, Cal worked with the UK’s National Institute for Health Research (NIHR) Applied Research Collaboration North West Coast (ARC NWC) and the UK Research & Innovation (UKRI) 3DBioNet network. He...

Access and affordability of gene therapies at TMM2020

We heard it first. If you attended the virtual Vancouver version of the 2020 Till & McCulloch Meetings, you had the opportunity to hear from Dr. Janet Rossant, Chair of the Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada, giving us a...